Compare
Abbott Laboratories vs Steris (ABT vs STE)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Abbott Laboratories (ABT) returned -11.7% and Steris (STE) +3.8%; so far this year the figures are -12.3% and -0.5%.
Abbott Laboratories is the larger company by market value, about 7.8 times the size of Steris.
On trailing earnings, ABT trades at 40.9 times and STE at 31.8 times.
Revenue grew +10.0% at ABT and +8.1% at STE over the last year.
ABT yields 2.29%. STE yields 0.77%.
Data as of the latest close. Not investment advice.
Relative performance
| ABT | STE | |
|---|---|---|
| Price | $109.93 | $252.30 |
| 1-day | -3.23% | -0.72% |
| YTD | -12.26% | -0.48% |
| 1 year | -11.73% | +3.75% |
| 3 years | +15.70% | +18.48% |
| Market cap | $190.4B | $24.5B |
| P/E | 40.9 | 31.8 |
| P/S | 3.95 | 3.97 |
| P/B | 3.73 | 3.38 |
| Revenue growth | +10.00% | +8.10% |
| EPS growth | -66.20% | — |
| Gross margin % | 56.9 | 44.6 |
| Net margin % | 9.7 | 13.4 |
| ROE % | 9.2 | 11.4 |
| Debt / equity | 0.61 | 0.26 |
| FCF yield % | 3.5 | 3.8 |
| Dividend yield % | 2.29 | 0.77 |
| Beta | 0.06 | 0.37 |
| RSI (14) | 58.5 | 73.1 |
| Technical rating |